By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Zogenix, Inc. 

12760 High Bluff Drive
Suite 130
San Diego  California  92130  U.S.A.
Phone: 858-259-1165 Fax: 858-259-1166



Start Up

Company News
Zogenix, Inc. (ZGNX) Submits Modified Formulation Of Zohydro® ER With Potential Abuse Deterrent Properties For FDA Review 10/1/2014 7:58:21 AM
Zogenix, Inc. (ZGNX) Release: New Data Shows Zohydro® ER Reduced Pain And Improved Function In People With Chronic Pain 9/18/2014 11:17:51 AM
Zogenix, Inc. (ZGNX) To Participate In Morgan Stanley (MST) Global Healthcare Conference 2014 9/3/2014 7:35:37 AM
Zogenix, Inc. (ZGNX) Release: Zohydro® ER Demonstrates Sustained 12-Hour Pain Relief 9/2/2014 8:26:35 AM
Does Zogenix, Inc. (ZGNX) Need a Painkiller? A Drugmaker Struggles With Controversy 8/8/2014 6:31:37 AM
Zogenix, Inc. (ZGNX) Reports Second Quarter 2014 Financial Results 8/5/2014 3:22:23 PM
Zogenix, Inc. (ZGNX) Announces Departure Of Chief Commercial Officer, Scott Shively 8/4/2014 7:50:04 AM
Zogenix, Inc. (ZGNX) Announces Appointment Of David Brushwood, J.D., R.Ph., To External Safe Use Board 7/17/2014 6:48:41 AM
Zogenix, Inc. (ZGNX) Announces New Patent Valid Through 2032 For DosePro® Needle-Free Delivery System 7/14/2014 7:57:20 AM
Zogenix, Inc. (ZGNX) Reports Positive Development On U.S. District Court Ruling 7/9/2014 10:33:00 AM